"Point of no return (PNR)" in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR

Journal of Nephrology

Volumn 18, Issue 6, 2005, Pages 690-695

  Komatsu, Hiroyuki ^a   Fujimoto, Shouichi ^a   Sato, Yuji ^a   Hara, Seiichiro ^a   Yamada, Kazuhiro ^a   Morita, Satoshi ^b   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

End stage renal disease; Hypertension; IgA nephropathy; Point of no return; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; STEROID;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RENOVASCULAR HYPERTENSION; RISK FACTOR;

ADULT; BIOPSY; BLOOD PRESSURE; CREATININE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 30644459093     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-27.
2. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide: A neglected disease in the United States? Am J Med 1988; 84: 129-32.
3. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-37.
4. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-96.
5. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-48.
6. D'Amico G, Ragni A, Gandini E, Fellin G. Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol 1993; 104: 6-13.
7. Schöll U, Wastl U, Risler T, Braun N, Grabensee B, Heering P, Schollmeyer P, Zäuner I, Stein G, Fünfstück R, Keller F. The "point of no return" and the rate of progression in the natural history of IgA nephritis. Clin Nephrol 1999; 52: 285-92.
8. Tomino Y, Sakai H; Special Study group (IgA nephropathy) on Progressive Glomerular Disease. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003; 7: 93-7.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461-70.
10. Sato Y, Fujimoto S, Yamada K, Hara S, Eto T. Analysis of factors affecting the course of renal diseases progression in patients with established renal insufficiency. Jpn J Nephrol 2003; 45: 372-7.
11. Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med 1992; 84: 619-27.
12. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207.
13. Geddes CC, Rauta V, Grönhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 20013; 18: 1541-8.
14. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Ren Fail 2005; 27: 45-52.
15. Rauta V, Finne P, Fagerudd J, Rosenlöf K, Törnroth T, Grönhagen-Riska C. Factors associated with progression of IgA nephropathy are related to renal function - a model for estimating risk of progression in mild disease. Clin Nephrol 2002; 58: 85-94.
16. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-35.
17. Donadio JV, Bergstralh EJ, Grande JP, Radenicher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002; 17: 1197-203.
18. Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy. Nephron 2002; 90: 432-41.
19. Vleming LJ, de Fijter JW, Westendrop RG, Daha MR, Brujin JA, van Es LA. Histomorphometric correlates of renal failure in IgA nephropathy. Clin Nephrol 1998; 49: 337-44.
20. Li PK, Ho KK, Szeto CC, Yu L, Lai FM. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant 2002; 17: 64-9.